These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10605426)

  • 1. [Do vitamin D3 and analogs have an antipsoriatic effect?].
    Mrowietz U
    Dtsch Med Wochenschr; 1999 Nov; 124(47):1437. PubMed ID: 10605426
    [No Abstract]   [Full Text] [Related]  

  • 2. [Derivatives of cholecalciferol in the treatment of psoriasis].
    Aĭziatulov RF; Iukhymenko VV
    Lik Sprava; 2003; (2):8-12. PubMed ID: 12774464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of vitamin D in dermatology.
    Kragballe K
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S72-6. PubMed ID: 9344190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measures for osteoporosis in the dermatological field--vitamin D3 and bisphosphonate].
    Okada N
    Clin Calcium; 2004 Oct; 14(10):145-9. PubMed ID: 15577149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficiency of calcium and vitamin D3 in the treatment of steroid osteoporosis in patients with hormone dependent bronchial asthma].
    Ememl'ianov AV; Shevelev SE; Murzin BA; Amosov VI
    Ter Arkh; 1999; 71(11):68-9. PubMed ID: 10626343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Active vitamin D3 therapy for gulucocorticoid-induced osteoporosis].
    Nakayama H
    Clin Calcium; 2006 Jul; 16(7):1201-7. PubMed ID: 16816482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of new antipsoriatic antedrug candidates having 16-en-22-oxa-vitamin D3 structures.
    Shimizu K; Kawase A; Haneishi T; Kato Y; Kinoshita K; Ohmori M; Furuta Y; Emura T; Kato N; Mitsui T; Yamaguchi K; Morita K; Sekiguchi N; Yamamoto T; Matsushita T; Shimaoka S; Sugita A; Morikawa K
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3323-9. PubMed ID: 16630723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activate vitamin D3 or bisphosphonate in glucocorticoid-induced osteoporosis].
    Imanishi Y; Nishizawa Y
    Clin Calcium; 2006 Nov; 16(11):1844-50. PubMed ID: 17079851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vitamin D3 analogs, oral fumaric acid, TNF-alpha antibodies. New hope for patients with psoriasis].
    Jäckle R
    MMW Fortschr Med; 2001 Oct; 143(41):4-8. PubMed ID: 11721660
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vitamin D 3 analogs, e new therapy for psoriasis].
    van de Kerkhof PC; de Jong EM; Arnold WP; de Mare S; Hol CW
    Ned Tijdschr Geneeskd; 1993 Jan; 137(5):232-6. PubMed ID: 8381921
    [No Abstract]   [Full Text] [Related]  

  • 11. Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: results from the 24-week extension of a 15-week randomized, controlled trial.
    Binkley N; Ringe JD; Reed JI; Ljunggren O; Holick MF; Minne HW; Liu M; Lamotta A; West JA; Santora AC
    Bone; 2009 Apr; 44(4):639-47. PubMed ID: 19185560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of osteoporosis with active vitamin D3].
    Katagiri H
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():392-6. PubMed ID: 15035158
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel therapeutic approaches to psoriasis.
    Griffiths CE
    Hosp Med; 1998 Jul; 59(7):539-42. PubMed ID: 9798542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prescribe topical treatments for psoriasis].
    Lorette G; Fontès V
    Rev Prat; 2004 Jan; 54(1):40-2. PubMed ID: 15049598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms.
    van de Kerkhof PC
    Br J Dermatol; 1995 May; 132(5):675-82. PubMed ID: 7772470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D therapy in psoriasis.
    Araugo OE; Flowers FP; Brown K
    DICP; 1991; 25(7-8):835-9. PubMed ID: 1659041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evidence-based assessment of therapeutic agents of osteoporosis. Bisphosphonates, SERM and basic therapy in front].
    MMW Fortschr Med; 2003 Jul; 145(27-28):63. PubMed ID: 14587198
    [No Abstract]   [Full Text] [Related]  

  • 18. [Proceedings: Long-term treatment of osteoporosis using sodium fluoride and vitamin D3].
    Reutter FW; Olah AJ
    Helv Med Acta; 1974 May; 37(5-6):361-2. PubMed ID: 4369654
    [No Abstract]   [Full Text] [Related]  

  • 19. [Osteoporosis: calcium and vitamin D3 are the basis for prevention and therapy. A national disease that should not be].
    Orthopade; 1994 Jun; 23(3 Suppl [osteopor]):1-4. PubMed ID: 9211673
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical development plan: vitamin D3 and analogs.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():268-81. PubMed ID: 7616750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.